China reports the third case of cholera this year, and concept stocks are hype!Experts say it will not be popular

Zhongxin Jingwei, July 11th (Wang Yuling) On the 11th,#Wuhan University's cholera cases#topic to appear on the hot search, causing public attention.

At the same time, the A -share market was moving, and Ryome Pharmaceutical, which was related to the control of cholera, rose 3.86%of Lianhuan Pharmaceuticals, and Li Sheng Pharmaceuticals rose 4.36%.

No new cases are found at present

According to public information, cholera is a kind of acute diarrhea infectious disease caused by the contaminated foods or water intake, which is stipulated in the "Infectious Disease Prevention Law".

The symptoms of cholera are mainly diarrhea, and it will also appear with vomiting symptoms. Very severe diarrhea often causes greater harm to the human body, and will cause symptoms such as dehydration, leading to danger of life.

In the source of infection, Zhao Shuguang, deputy chief physician of the People's Hospital of Taihe County, Fuyang City, Anhui Province, asked the doctor in 39 that the patient and the bacteria were the source of the infection of cholera. Milial feces can contain 7-9 vibration bacteria, which plays an important role in the spread of the disease. After the choice is excreted with the patient's feces and vomit, it is infected with the contaminated water, food, hands, or flies, or cockroaches as the medium. Water -type communication is the most important way for cholera.

For our country, this year is the third report of cholera since this year. According to the national statutory infectious disease epidemic situation published by the National Health and Health Commission's Disease Control and Control Bureau, in January and March 2022, each report was reported. In 2021, there were 5 cases of choice in the country and no death cases. In 2020, there were 11 cases of choice reports in the country, and there were no death cases.

Related stocks

After the cholera news appeared, the A -share market part of the stocks that were related to cholera had a change of stocks, including Raiamei Pharmaceuticals, Lianhuan Pharmaceuticals, and Lisheng Pharmaceuticals.

Among them, Laimei Pharmaceutical's industry rose rapidly, touching the daily limit, closing up 20.05%to 4.85 yuan per share. The main products of Laimei Pharmaceuticals include anti -tumor drugs, digestive system drugs, anti -infective drugs and other fields.

Lianhuan Pharmaceutical once rose more than 7%, closing up 3.86%to 10.77 yuan per share. According to the announcement issued by Lianhuan Pharmaceutical on April 15, the company's polycons hydrochloride tablets are evaluated by generic drugs and are broad -spectrum bacteriostatic agents. The medicine can still be used to treat cholera. It can also be used to prevent malignant malaria and hook -end spiral infections.

In addition, in terms of virus testing, Mingde Bio rose 5%to 78.15 yuan per share. On the investor interactive platform, some investors asked if they had tested cholera virus products, and Mingde Bio responded that testing products were under R & D.

Hot -view creatures rose 2.43%to 79.11 yuan per share. Hot -viewing creatures have stated in the investor interactive platform that their biological warfare test indicators include cholera viblus O139 groups and choleraja O1 groups.

Will it be popular?

Zhongxin Jingwei noticed that recently including Spain, Iraq, Mozambique, Afghanistan and other countries reporting cholera cases. Among them, the case of Afghano cholera infection increased significantly. According to the data released by Hehrandan officials in Afghanistan, on July 10, local time, 20 people died of cholera within the past 24 hours and 120 were infected.

At the same time, there are regional re -reporting cholera after many years. On June 22, local time, the Government of Castilla-Ramanta, Spain, reported that a minor in Madrid was infected with cholera after drinking direct drinking water. According to the Spanish Ministry of Health, this is the first cholera case in Spain since 1979.

Will cholera spread large -scale?

The virusist Chang Rongshan told Zhongxin Jingwei that it is very early to find cholera, and it is unlikely to become popular. Jin Dongyan, a professor and virus expert at the School of Biomedicine, University of Hong Kong, also stated, "Chilen is unlikely to be popular because the transmission of cholera is not a simple person. Its main communication channels are pollution of water and food. Washing your hands and cooking are not infected with cholera. "Jin Dongyan said. (For more report clues, please contact Wang Yuling, the author of this article: [email protected]) (Zhongxin Jingwei APP)

(The views in the article are for reference only, do not constitute investment suggestions, have risks in investment, and need to be cautious to enter the market.)

Copyright Copyright Copyright, without written authorization, no unit or individual may reprint, extract or use it in other ways.

Editor in charge: Li Zhongyuan

Pay attention to the official WeChat public account of JWVIEW (JWVIEW) to get more elite financial information.

- END -